ZALICUS PUBLISHES DATA ON SODIUM CHANNEL COMPOUND IN PAIN MODELS.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 2, p. 9
- Publication type:
- Article
Works matching IS 21588333 AND DT 2011 AND VI 8 AND IP 2
Results: 14
1
2
HOW TO ELIMINATE NARCISSISM OVERNIGHT: DSM-V and the Death of Narcissistic Personality Disorder.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
3
SEXUAL BEHAVIOR IN BORDERLINE PERSONALITY: A Review.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 2, p. 14
- By:
- Publication type:
- Article
4
Factitious Disorder as Repeated Diabetic Ketoacidosis: A Case Report.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
5
TREATING PANIC DISORDER: A Psychotherapeutic Case.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
6
Lisdexamfetamine Dimesylate for the Treatment of Attention Deficit Hyperactivity Disorder in Adults With a History of Depression or History of Substance Use Disorder.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 2, p. 28
- By:
- Publication type:
- Article
7
SUICIDE ATTEMPTS AND BORDERLINE PERSONALITY DISORDER SYMPTOMATOLOGY IN A CARDIAC STRESS TEST POPULATION.
- Published in:
- 2011
- By:
- Publication type:
- Letter
8
SEROTONIN PLAYS ROLE IN MANY AUTISM CASES, STUDIES CONFIRM.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 2, p. 10
- Publication type:
- Article
9
RESEARCHERS HAVE FOUND HOW BRAIN CELLS CONTROL THEIR MOVEMENT TO FORM THE CEREBRAL CORTEX.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 2, p. 10
- Publication type:
- Article
10
SETTING UP A DEATH ROW PSYCHIATRY PROGRAM.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 2, p. 19
- By:
- Publication type:
- Article
11
ABILIFY (ARIPIPRAZOLE) APPROVED FOR MAINTENANCE TREATMENT OF BIPOLAR I DISORDER AS AN ADJUNCT TO EITHER LITHIUM OR VALPROATE.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 2, p. 8
- Publication type:
- Article
12
FOREST LABORATORIES, INC. AND GEDEON RICHTER PLC ANNOUNCE RESULTS FROM A PHASE II STUDY OF CARIPRAZINE AS ADJUNCTIVE THERAPY IN MAJOR DEPRESSIVE DISORDER.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 2, p. 8
- Publication type:
- Article
13
FDA APPROVES INTUNIV (GUANFACINE) EXTENDED-RELEASE TABLETS FOR USE AS ADJUNCTIVE THERAPY TO STIMULANTS FOR THE TREATMENT OF ADHD IN CHILDREN AND ADOLESCENTS.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 2, p. 8
- Publication type:
- Article
14
Editor's Message. Issue Highlights, February 2011.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 2, p. 3
- By:
- Publication type:
- Article